Condition: Peripheral Blood Stem Cell Transplantation · Sponsor: Chinese PLA General Hospital
The purpose of this study is to determine the efficacy and safety of Ruxolitinib and Chidamide intensified conditioning regimen in patients with Acute B cell Lymphoblast leukemia Underwenting Haploidenticl Peripheral blood Stem Cell Transplantation.
This description comes directly from the study's public registry record.
Daihong Liu · 86-13681171597 · daihongrm@163.com
Liping Dou · 96-13681207138 · lipingruirui@163.com
Always discuss trial participation with your own doctor first.
| Chinese PLA General Hospital | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05088226